Mesa Biotech Accula AR Analizer Lot: RD2101A064

Mesa Biotech Accula AR Analyzer Lot: RD2101A064

**Unit has been tested to specifications. Cassettes NOT included. Buyer can expected same unit as the picture with 30-Day warranty. See photos for further details.

 Mesa Biotech Accula AR Analyzer is an affordable machine with sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, launched its respiratory syncytial virus test (RSV) at AACC. Mesa designs, develops, manufactures and commercializes next-generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the POC. Mesa’s Accula System is a sample-to-answer palm-sized, reusable dock with single-use test cassettes (NOT Included). The novel molecular test system is a visually interpreted, FDA-cleared, CLIA-waived PCR platform with the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassay tests, while providing the superior sensitivity, specificity and information content of laboratory-based PCR testing accula System's RSV and Flu A/Flu B molecular tests.

 The Accula Test performed on the Accula Dock or the Silaris  Dock is a molecular in vitro diagnostic test utilizing polymerase chain reaction (PCR) and lateral flow technologies for the qualitative, visual detection of nucleic acid from SARS-CoV-2 in
clinician-collected nasal or nasal mid-turbinate swab specimens or clinician instructed self-collected (collected on site) nasal swab specimens, collected from individuals suspected of COVID-19 by their healthcare provider.